Beyond Statins: A Practical Plan to Incorporate the New Lipid Agents
Impossible d'ajouter des articles
Échec de l’élimination de la liste d'envies.
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
-
Lu par :
-
De :
À propos de ce contenu audio
Please join our special guest, Dr. Benjamin Romer from Ohio State University, as we address the current state of lipid therapy in both primary and secondary prevention patients. He addresses a practical approach to the issue of statin intolerance, then reviews the newer agents including ezetimide and bempedoic acid, as well as the newer percutaneous agents, with a focus on practical tips for implementation. We wrap up with a discussion on the role of coronary calcium scoring to guide therapeutic decisions in select patients.
For more information, see the 2022 ACC Expert Consensus Pathway on the role of Nonstatin Therapies.
Please subscribe to receive updated episodes automatically! Visit https://www.ohioacc.org/cardiohio-podcast/.
“Upbeat Party” by scottholmesmusic.com
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !